Cost-effectiveness of physical activity in the management of COPD patients in the UK

References

• Global Initiative for Chronic Obstructive Lung DiseasePocket Guide to COPD Diagnosis, Management, and Prevention – A Guide to COPD Diagnosis, Management, and Prevention2017 Available from: http://goldcopd.org/pocket-guide-copd-diagnosis-management-prevention-2016/Accessed November 23, 2017
   Google Scholar
• WHOChronic obstructive pulmonary disease (COPD) Available from: http://www.who.int/respiratory/copd/en/Accessed November 23, 2017
   Google Scholar
• CorhayJLDangDNvan CauwenbergeHLouisRPulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapyInt J Chron Obstruct Pulmon Dis20149273924368884
   PubMed Web of Science ®Google Scholar
• SnellNStrachanDHubbardRGibsonJGruffydd-JonesKJarroldIS32 Epidemiology of chronic obstructive pulmonary disease (COPD) in the uk: findings from the british lung foundation’s ‘respiratory health of the nation’ projectThorax201671Suppl 3A20A20
   Google Scholar
• Garcia-AymerichJLangePBenetMSchnohrPAntóJMRegular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort studyAm J Respir Crit Care Med2007175545846317158282
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJLangePBenetMSchnohrPAntóJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax200661977277816738033
   PubMed Web of Science ®Google Scholar
• ZafariZBryanSSinDDConteTKhakbanRSadatsafaviMA Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary DiseaseValue Health201720115216228212957
   PubMed Web of Science ®Google Scholar
• ExuzidesAColbyCBriggsARiseboroughNBakerTMIsmailaASome statistical considerations in estimating a disease progression model for chronic obstructive pulmonary disease (COPD)Value in Health2014173A183
   Web of Science ®Google Scholar
• PunekarYSRobertsGIsmailaAO’LearyMCost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UKCost Eff Resour Alloc CE2015 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676898/Accessed November 25, 2017
   Google Scholar
• BriggsAHBakerTRisebroughNADevelopment of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort ModelMed Decis Making201737446948027317436
   PubMed Web of Science ®Google Scholar
• TabbererMGonzalez-McquireSMuellerovaHDevelopment of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary DiseaseMed Decis Making201737444045227486218
   PubMed Web of Science ®Google Scholar
• MiravitllesMGáldizJBHuertaAVillacampaACarcedoDGarcia-RioFCost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patientsInt J Chron Obstruct Pulmon Dis20161112313226848262
   PubMed Web of Science ®Google Scholar
• HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcgarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
   PubMed Web of Science ®Google Scholar
• National Health ServiceHealth Survey for England – 2009, Trend tables2010 Available from: https://digital.nhs.uk/catalogue/PUB00445Accessed December 17, 2017
   Google Scholar
• RamosMHaughneyJHenryNLindnerLLamotteMCost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPDClinicoecon Outcomes Res2016844545627672337
   PubMed Web of Science ®Google Scholar
• British Thoracic Society COPD ConsortiumSpirometry in practiceA Practical Guide to Using Spirometry in Primary CareSecond ed2005 https://www.brit-thoracic.org.uk/document-library/delivery-of-respiratory-care/spirometry/spirometry-in-practice-a-practical-guide-(2005)/Accessed October 10, 2018
   Google Scholar
• DransfieldMTKunisakiKMStrandMJAcute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary DiseaseAm J Respir Crit Care Med2017195332433027556408
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
   PubMed Web of Science ®Google Scholar
• AliMSTalwarDJainSKThe effect of a short-term pulmonary rehabilitation on exercise capacity and quality of life in patients hospitalised with acute exacerbation of chronic obstructive pulmonary diseaseIndian J Chest Dis Allied Sci2014561131924930202
   PubMedGoogle Scholar
• IncorvaiaCRussoAForesiAEffects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST studyEur J Phys Rehabil Med201450441942624691247
   PubMed Web of Science ®Google Scholar
• ElkhateebNBElhadidiAAMasoodHHMohammedARPulmonary rehabilitation in chronic obstructive pulmonary diseaseEgypt J Chest Dis Tuberc2015642359369
   Google Scholar
• KarabisAMocarskiMEijgelshovenIBergmanGEconomic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 yearsClinicoecon Outcomes Res2014617518524741321
   PubMedGoogle Scholar
• BoutouAKShrikrishnaDTannerRJLung function indices for predicting mortality in COPDEur Respir J201342361662523349449
   PubMed Web of Science ®Google Scholar
• NHSNHS Smoking Cessation Services (Scotland)Information Services Division, Publication report2016 Available from: http://www.isdscotland.org/Health-Topics/Public-Health/Publications/2016-10-04/2016-10-04-SmokingCessation-Report.pdfAccessed October 10, 2018
   Google Scholar
• Rutten-van MölkenMPOostenbrinkJBTashkinDPBurkhartDMonzBUDoes quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?Chest200613041117112817035446
   PubMed Web of Science ®Google Scholar
• WackerMEJörresRAKarchAAssessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbiditiesBMC Pulm Med20161617027160582
   PubMed Web of Science ®Google Scholar
• EarnshawSRWilsonMRDalalAACost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPDRespir Med20091031122119010652
   PubMed Web of Science ®Google Scholar
• OostenbrinkJBRutten-van MölkenMPMonzBUFitzgeraldJMProbabilistic Markov model to assess the cost-effectiveness of broncho-dilator therapy in COPD patients in different countriesValue Health200581324615841892
   PubMed Web of Science ®Google Scholar
• SpencerMBriggsAHGrossmanRFRanceLDevelopment of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary diseasePharmacoeconomics200523661963715960557
   PubMed Web of Science ®Google Scholar
• PatersonCLanganCEMckaigGAAssessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D)Qual Life Res20009552152711190007
   PubMed Web of Science ®Google Scholar
• NHS NetworkLRN’s COPD Value Pyramid Available from: https://www.networks.nhs.uk/nhs-networks/london-lungs/latest-edition-of-thorax-publicationAccessed December 17, 2017
   Google Scholar
• LanghammerAJohnsenRGulsvikAHolmenTLBjermerLForced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag StudyEur Respir J200118577077911757626
   PubMed Web of Science ®Google Scholar
• HedenströmHMalmbergPFridrikssonHVReference values for lung function tests in men: regression equations with smoking variablesUps J Med Sci19869132993103811032
   PubMed Web of Science ®Google Scholar
• RocaJBurgosFSunyerJReferences values for forced spirometry. Group of the European Community Respiratory Health SurveyEur Respir J1998116135413629657579
   PubMed Web of Science ®Google Scholar
• FalaschettiELaihoJPrimatestaPPurdonSPrediction equations for normal and low lung function from the Health Survey for EnglandEur Respir J200423345646315065839
   PubMed Web of Science ®Google Scholar
• HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general U.S. populationAm J Respir Crit Care Med199915911791879872837
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flowsEur Respir J19936Suppl 16540
   PubMed Web of Science ®Google Scholar
• QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
   PubMed Web of Science ®Google Scholar
• VestboJPapiACorradiMSingle inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialLancet2017389100821919192928385353
   PubMed Web of Science ®Google Scholar
• PavordIDJonesPWBurgelPRRabeKFExacerbations of COPDInt J Chron Obstruct Pulmon Dis201611Spec Iss213026937187
   PubMedGoogle Scholar
• HoogendoornMFeenstraTLAsukaiYCost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosValue Health201417552553625128045
   PubMed Web of Science ®Google Scholar
• Office of National StatisticsNational life tables 2012–20142010 Available from: http://webarchive.nationalarchives.gov.uk/20160106035247/http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77-394848Accessed November 29, 2017
   Google Scholar
• AnnemansLLamotteMClarysPvan den AbeeleEHealth economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseasesEur J Cardiovasc Prev Rehabil200714681582418043305
   PubMedGoogle Scholar
• CradockALBarrettJLKenneyELUsing cost-effectiveness analysis to prioritize policy and programmatic approaches to physical activity promotion and obesity prevention in childhoodPrev Med201795SupplS17S2727773710
   PubMed Web of Science ®Google Scholar
• CobiacLJVosTBarendregtJJCost-effectiveness of interventions to promote physical activity: a modelling studyPLoS Med200967e100011019597537
   PubMed Web of Science ®Google Scholar
• AtsouKCrequitPChouaidCHejblumGSimulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in FrancePLoS One2016116e015651427327159
   PubMed Web of Science ®Google Scholar
• BurnsDKWilsonECBrownePThe Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled TrialAppl Health Econ Health Policy201614110511526346590
   PubMed Web of Science ®Google Scholar
• ZwerinkMEffingTKerstjensHACost-Effectiveness of a Community-Based Exercise Programme in COPD Self-ManagementCOPD201613221422326623496
   PubMedGoogle Scholar
• GillespiePO’SheaECaseyDThe cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trialBMJ Open2013311e003479
   Web of Science ®Google Scholar
• HaileyDJacobsPSticklandMChuckAMarciniukDMayerIPulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease: Clinical, Economic, and Budget Impact Analysis [Technology report number 126]OttawaCanadian Agency for Drugs and Technologies in Health2010Report No.: 126 Available from: https://www.cadth.ca/media/pdf/H0482_COPD_tr_e.pdfAccessed October 10, 2018
   Google Scholar
• CoultasDBJacksonBERussoRHome-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary OutcomesAnn Am Thorac Soc201815447047829283670
   PubMed Web of Science ®Google Scholar